Objective To explore the correlation between peripheral low molecular mass peptide 2(LMP2), resolvin D1(RVD1), and cognitive impairment(CI) in acute ischemic stroke(AIS) patients. Methods From January 2021 to July 2024, 216 AIS patients and 65 healthy controls were enrolled. Followed for 6 months,...
Detail |
PDF